Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients

Cardiovascular Pathology

Volumn 16, Issue 2, 2007, Pages 69-74

  Demir, Mesut ^a   Acartürk, Esmeray ^a   Inal, Tamer ^a   Attila, Gülen ^a   Dönmez, Yurdaer ^a   Avkaroǧullari, Mahir ^a   Çayli, Murat ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Diastolic dysfunction; Hypertension; Procollagen type I carboxy terminal peptide

Indexed keywords

COLLAGEN; PROCOLLAGEN; PROCOLLAGEN TYPE 1 CARBOXYL TERMINAL PEPTIDE; UNCLASSIFIED DRUG;

ADULT; APPARATUS; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DIASTOLE; DIASTOLIC DYSFUNCTION; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

ADULT; BIOLOGICAL MARKERS; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33847036604     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2006.09.010     Document Type: Article

References (35)

1. Jalil J., Doering C., Janicki J., Pick R., Shroff S., and Weber K. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 64 (1989) 1041-1050
2. Bashey R., Cox R., McCann J., and Jimenez S. Changes in collagen biosynthesis, types, and mechanics of aorta in hypertensive rats. J Lab Clin Med 113 (1989) 604-611
3. Eghbali M., and Weber K. Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression. Mol Cell Biochem 96 (1990) 1-14
4. Lopez B., Gonzalez A., Varo N., Laviades C., Querejeta R., and Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 38 (2001) 1222-1226
5. Vasan R., Larson M., Benjamin E., Evans J., Reiss C., and Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33 (1999) 1948-1955
6. Lopez B., Querejeta R., Varo N., Gonzalez A., Larman M., Martinez Ubago J., et al. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 104 (2001) 286-291
7. Lindsay M., Maxwell P., and Dunn F. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 40 (2002) 136-141
8. Schwartzkopff B., Brehm M., Mundhenke M., and Strauer B. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Hypertension 36 2 (2000) 220-225
9. Diez J., Querejeta R., Lopez B., Gonzalez A., Larman M., and Martinez Ubago J. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 105 21 (2002) 2512-2517
10. Diez J., Laviades C., Mayor G., Gil M., and Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 91 (1995) 1450-1456
11. Chobanian A., Bakris G., Black H., Cushman W., Green L., Izzo J., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (The JNC 7 Report). JAMA 289 (2003) 2560-2572
12. Gardin J., Adams D., Douglas P., Feigenbaum H., Forst D., Fraser A., et al. Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr 15 (2002) 275-290
13. Devereux R., and Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55 (1977) 613-618
14. Quinones M. Doppler assessment of left ventricular diastolic function. In: Nanda N. (Ed). Doppler echocardiography. 2nd ed. (1993), Lea & Febiger, Philadelphia 197-215
15. Rodriguez L., Garcia M., Ares M., Griffin B., Nakatani S., and Thomas J. Assessment of mitral annular dynamics during diastole by Doppler tissue imaging: comparison with mitral Doppler inflow in subjects without heart disease and in patients with left ventricular hypertrophy. Am Heart J 131 (1996) 982-987
16. Matsumura Y., Elliot P., Virdee M., Sorajja P., Doi Y., and McKenna W. Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity. Heart 87 (2002) 247-251
17. Isaaz K. Tissue Doppler imaging for the assessment of left ventricular systolic and diastolic functions. Curr Opin Cardiol 17 (2002) 431-442
18. Rosei E., and Muiesan M. Pathophysiology and treatment of hypertensive left ventricular hypertrophy. Dialogues Cardiovasc Med 9 (2004) 3-18
19. Weber K. Fibrosis and hypertensive heart disease. Curr Opin Cardiol 15 (2000) 264-272
20. Weber K., Brilla C., Cleland J., Cohn J., Hansson L., Heagerty A., et al. Cardioreparation and the concept of modulating cardiovascular structure and function. Blood Press 2 (1993) 6-21
21. Assayag P., Carre F., Chevalier B., Delcayre C., Mansier P., and Swynghedauw B. Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype: I. Fibrosis. Cardiovasc Res 34 (1997) 439-444
22. Pahor M., Bernabei R., Sgadari A., Gambassi G., Lo P., Giudice L., et al. Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension 18 (1991) 148-157
23. Remme W. Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy. Cardiovasc Drugs Ther 17 (2003) 349-360
24. Ciulla M., Paliotti R., Hess D., Tjahja E., Campbell S., Magrini F., et al. Echocardiographic patterns of myocardial fibrosis in hypertensive patients: endomyocardial biopsy versus ultrasonic tissue characterization. J Am Soc Echocardiogr 10 (1997) 657-664
25. Diez J. Hypertension and left ventricular hypertrophy. How important is it to assess and attempt to control cardiac fibrosis in hypertension?. Dialogues Cardiovasc Med 9 (2004) 28-32
26. Querejeta R., Lopez B., Gonzalez A., Sanchez E., Larman M., Martinez Ubago J., et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 110 (2004) 1263-1268 [Electronic publication 2004 Aug 16]
27. Laviades C., Varo N., Fernandez J., Mayor G., Gil M., Monreal I., et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 98 (1998) 535-540
28. Laviades C., Varo N., and Diez J. Transforming growth factor beta in hypertensives with cardiorenal damage. Hypertension 36 (2000) 517-522
29. Matsubara L., Matsubara B., Okoshi M., Franco M., and Cicogna A. Myocardial fibrosis rather than hypertrophy induces diastolic dysfunction in renovascular hypertensive rats. Can J Physiol Pharmacol 75 (1997) 1328-1334
30. Kato S., Koide M., Cooper G., and Zile M. Effects of pressure- or volume-overload hypertrophy on passive stiffness in isolated adult cardiac muscle cells. Am J Physiol 271 (1996) H2575-H2583
31. Maceira A., Barba J., Beloqui O., and Diez J. Ultrasonic backscatter and diastolic function in hypertensive patients. Hypertension 40 (2002) 239-243
32. Querejeta R., Varo N., Lopez B., Larman M., Artinano E., Etayo J., et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 101 (2000) 1729-1735
33. Voutilainen S., Kupari M., Hippelainen M., Karppinen K., Ventila M., and Heikkila J. Factors influencing Doppler indexes of left ventricular filling in healthy persons. Am J Cardiol 68 (1991) 653-659
34. Jarnert C., Mejhert M., Ring M., Persson H., and Ender M. Doppler tissue imaging in congestive heart failure patients due to diastolic or systolic dysfunction: a comparison with Doppler echocardiography and the atrio-ventricular plane displacement technique. Eur J Heart Fail 21 (2000) 151-160
35. Sato A., Takane H., and Saruta T. High serum level of procollagen type III amino-terminal peptide contributes to the efficacy of spironolactone and angiotensin-converting enzyme inhibitor therapy on left ventricular hypertrophy in essential hypertensive patients. Hypertens Res 24 (2001) 99-104